TY - BOOK ID - 5338434 TI - Double standards in medical research in developing countries PY - 2004 VL - 2 SN - 0521833884 0521541700 1107160952 9786610540464 0511215398 0511217188 0511315791 0511495358 128054046X 0511211813 0511213581 9780521541701 PB - Cambridge : Cambridge University Press, DB - UniCat KW - Medical care KW - Medical ethics KW - Public health KW - Soins médicaux KW - Ethique médicale KW - Santé publique KW - Research KW - Recherche KW - Human Experimentation KW - Clinical Trials as Topic KW - Research Subjects KW - Ethics, Research KW - Ethics, Business KW - Developing Countries KW - Soins médicaux KW - Ethique médicale KW - Santé publique KW - Law KW - General and Others KW - Community health KW - Health services KW - Hygiene, Public KW - Hygiene, Social KW - Public health services KW - Public hygiene KW - Social hygiene KW - Health KW - Human services KW - Biosecurity KW - Health literacy KW - Medicine, Preventive KW - National health services KW - Sanitation KW - Biomedical ethics KW - Clinical ethics KW - Ethics, Medical KW - Health care ethics KW - Medicine KW - Bioethics KW - Professional ethics KW - Nursing ethics KW - Social medicine KW - Delivery of health care KW - Delivery of medical care KW - Health care KW - Health care delivery KW - Healthcare KW - Medical and health care industry KW - Medical services KW - Personal health services KW - Moral and ethical aspects KW - Medical care - Research - Developing countries KW - Medical ethics - Developing countries KW - Public health - Research - Developing countries UR - https://www.unicat.be/uniCat?func=search&query=sysid:5338434 AB - This book examines the ethical controversies that have surrounded the design and conduct of international medical research sponsored by industrialized countries or industry, and carried out in developing countries. The chief concern is that research subjects in developing countries may be exploited because sponsors of research employ double standards. One debate focuses on whether the standard of care provided to subjects of medical research in developing countries should be the same as what research subjects receive in North America and Europe. Other concerns are whether the process of obtaining informed consent in developing countries is adequate, and whether prior ethical review of research meets standards that are well established in the industrialized world. Recent international developments show that essential medications can be made affordable and accessible to developing countries, and that double standards need not prevail. ER -